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Abstract—Copper chelator cuprizone (CPZ) is neurotoxicant, which selectively disrupts oligodendroglial respira-
tory chain, leading to oxidative stress and subsequent apoptosis. Demyelination is, however, followed by spon-
taneous remyelination owing to the activation of intrinsic CNS repair mechanisms. To explore the participation of
metallothioneins (MTs) in these processes, in this study we analyzed the expression proﬁles of MT-I/II and their
receptor megalin (low-density lipoprotein receptor related protein-2) in the brain of mice subjected to diﬀerent
protocols of CPZ feeding. Experiments were performed in female C57BL/6 mice fed with 0.25% CPZ during 1,
3 and 5 weeks. They were sacriﬁced immediately after feeding with CPZ or 2 weeks after the withdrawal of CPZ.
The data showed that CPZ-induced demyelination was followed by high astrogliosis and enhanced expression
of MTs and megalin in white (corpus callosum and internal capsule) and gray matter of the brain (cortex, hip-
pocampus, and cerebellum). Moreover, in numerous cortical neurons and progenitor cells the signs of MT/mega-
lin interactions and Akt1 phosphorylation was found supporting the hypothesis that MTs secreted from the
astrocytes might directly aﬀect the neuronal diﬀerentiation and survival. Furthermore, in mice treated with CPZ
for 5 weeks the prominent MTs and megalin immunoreactivities were found on several neural stem cells and
oligodendrocyte progenitors in subgranular zone of dentate gyrus and subventricular zone of lateral ventricles
pointing to high modulatory eﬀect of MTs on adult neuro- and oligodendrogenesis. The data show that MT I/II
perform important cytoprotective and growth-regulating functions in remyelinating processes activated after
toxic demyelinating insults.  2018 The Author(s). Published by Elsevier Ltd on behalf of IBRO. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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metallothioneins I/II.INTRODUCTION
The complex molecular mechanisms contributing to the
de- and remyelination in multiple sclerosis (MS) and
other inﬂammatory and neurodegenerative diseases are
often investigated in the cuprizone (bis-cyclohexanone-o
xalyldihydrazone, CPZ) model of intoxication, since it
leads to reproducible induction of acute or chronic
demyelinating lesions followed by spontaneous
remyelination after withdrawal of cuprizone feeding
(Kipp et al., 2009; Be´nardais et al., 2013; Gudi et al.,
2014; Praet et al., 2014). It is assumed that induced
pathology and the selective vulnerability of mature oligo-
dendrocytes (OLGs) to apoptosis originate from copper
deﬁciency due to Cu chelation or from Cu entrapment
within the cell (Messori et al., 2007), since this leads tohttps://doi.org/10.1016/j.neuroscience.2018.07.009
0306-4522/ 2018 The Author(s). Published by Elsevier Ltd on behalf of IBRO.
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Abbreviations: CPZ, copper chelator cuprizone; DG, dentate gyrus;
GCL, granular cell layer; LDL-R, low-density lipoprotein receptor; MTs,
metallothioneins; OLGs, oligodendrocytes; OPCs, oligodendrocyte
progenitor cells; PBS, phosphate-buﬀered saline; PLA, proximity
ligation assay; ROIs, regions of interest; SVZ, subventricular zone.
69detrimental eﬀects on mitochondrial function and induce
the disturbance of energy metabolism in oligodendroglia
that require vast amounts of energy for myelin synthesis
(reviewed by (Torkildsen et al., 2008; Kipp et al., 2009,
2012; Skripuletz et al., 2011; Zendedel et al., 2013;
Praet et al., 2014). Subsequently, demyelinated axons
became more vulnerable to attacks by brain intrinsic
and extrinsic immune cells and inﬂammatory mediators
owing to the lack of trophic support by myelin sheaths
and higher energy demand for the conduction of action
potentials in the presence of higher Na+ channel density
(Smith and Lassmann, 2002; Craner et al., 2004;
Zendedel et al., 2013). Demyelination is, however, transi-
tory and followed by spontaneous remyelination which
depends on numerous factors that protect injured cells
and/or stimulate the proliferation of remaining oligoden-
drocyte progenitor cells (OPCs) and their diﬀerentiation
into mature OLGs that interact with the denuded axons
(Franklin and French-Constant, 2017). In this context it
was also emphasized that the remyelination might be
diminished not only due to precursor cell depletion, but
also owing to the presence of a nonpermissive local envi-
ronment and defective activation of signaling pathwaysons.org/licenses/by-nc-nd/4.0/).
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(Kipp et al., 2009; Praet et al., 2014).
A large body of evidence implies that to the later
events also contribute cysteine-rich metallothioneins
(MTs), which during CNS injury show both
neuroprotective and neuroregenerative properties
(Hidalgo et al., 2001; Aschner and West, 2005;
Penkowa, 2006; Fitzgerald et al., 2007; West et al.,
2008; Pedersen et al., 2009). Their function has been
attributed not only to intracellular free radical scavenging
and to zinc and copper regulation in injured cells (Coyle
et al., 2002; Maret, 2011) but also to the ability of secreted
MT to bind on surface receptors belonging to the family of
low-density lipoprotein receptor (LDL-R)-related proteins
(LRP), such as LRP-2/megalin and LRP-1, which in turn
activate the signal transduction pathways that support
neurite outgrowth and survival (Ambjørn et al., 2008;
Chung et al., 2008b; Asmussen et al., 2009; West et al.,
2011; Auderset et al., 2016). In this regard it was shown
that MT and its synthetic analog EmtinB might directly
stimulate neurite outgrowth and promote survival of cere-
bellar granule neurons in vitro (Ambjørn et al., 2008), as
well as that native MT-2A might block copper-mediated
deposition of insoluble extracellular b-amyloid (Ab) pla-
ques and toxicity in rat cortical neurons (Chung et al.,
2010). Accordingly, it was suggested that MTs might have
a signiﬁcant therapeutic potential in megalin-mediated
mechanisms, which are involved in the pathogenesis of
Alzheimer’s (AD) and other neuropathological diseases
(Ambjørn et al., 2008; Chung et al., 2008b; Asmussen
et al., 2009; West et al., 2011; Auderset et al., 2016).
Moreover, implying that similar anti-oxidant and anti-
inﬂammatory mechanisms might be activated also in
CPZ model of demyelination, in glial cells and in OLGs
and OPCs were found an overexpression of MT-I/II
mRNA and proteins, elevated levels of TGF-b and IL-10
and increased activities of NAD-linked cytoplasmic oxi-
doreductase and glycerolphosphate-3 dehydrogenase
(Biancotti et al., 2008).
In an attempt to provide further insights into the
potential neuroprotective function of MTs, in the present
study we made an immunohistochemical spatio-
temporal proﬁling of MT-I/II expression and distribution
throughout CNS tissue during acute and chronic CPZ
demyelination, induced by diﬀerent CPZ-feeding
protocol, with a focus on possible interaction of MT-I/II
with megalin/ LRP-2 and their involvement in processes
of de- and remyelination.EXPERIMENTAL PROCEDURES
Experimental animals
Experiments were performed on female C57BL/6 mice
(9–10 weeks of age). They were housed 4–5 per cage
under standard conditions of light, temperature and
humidity with unlimited access to food and water.
Experimental procedures involving animals complied
with Croatian laws and rules (NN 135/06; NN 37/13; NN
125/13; NN 055/2013) and with the guidelines set by
European Community Council Directive (86/609/EEC).Experimental protocol was approved by the Ethics
Committee of the University of Rijeka.Cuprizone administration
The cuprizone model was performed according to the
previously described protocols (Torkildsen et al., 2008;
Kipp et al., 2009; Zendedel et al., 2013). To induce
demyelination mice were fed with a 0.25% (w/w) cupri-
zone/CPZ) [ﬁnely powdered oxalic bis (cyclohexylidene-
hydrazide); Sigma–Aldrich C9012-25G; Germany]
homogeneously blended in the standard food for labora-
tory animals. Feeding lasted 1, 3 or 5 weeks and mice
were sacriﬁced next day after the expiration of the dietary
intoxication protocol or 2 weeks after the withdrawal of
CPZ given for 5 weeks (group 5+2 weeks). Control mice
received the same chow without cuprizone. At the end of
the experiment mice were anesthetized by combination of
Ketamine (80 mg/kg) and Xylasine (5 mg/kg), given by
intraperitoneal (i.p.) injection, transcardially perfused with
cold phosphate-buﬀered saline (PBS, 10 mM, pH 7.4) and
4% paraformaldehyde (PFA, SIGMA, Germany) and sub-
sequently sacriﬁced by exsanguinations in deep anesthe-
sia, according to the guidance of European Community
Council Directive (86/609/EEC) and recommendation of
National Centre for the Replacement, Reﬁnement and
Reduction of Animals in Research (www.nc3rs.org.uk).Tissue preparation for paraﬃn slices
Tissue samples of the brain were rapidly removed from
six animals/group, coronally or sagittally dissected after
perfusion and ﬁxed in 4% paraformaldehyde solution
(Sigma, Germany) during 24 h. Tissue was embedded
in paraﬃn wax and cut using HM 340E microtome
(Microtom, Germany). The tissue sections (4 mm) were
deparaﬃnized, rehydrated and subjected to heat-
induced antigen retrieval (0.01 M Sodium Citrate pH 6.0).Immunohistochemistry
Immunohistochemical labeling of MT I + II and megalin
proteins was performed on paraﬃn embedded tissues
using DAKO EnVision + System, Peroxidase (DAB) kit
according to the manufacturer’s instructions (DAKO
Cytomation, USA), as previously described (Jakovac
et al., 2011). Brieﬂy, slices were incubated with peroxi-
dase block to eliminate endogenous peroxidase activity.
After washing, mouse monoclonal anti-MT I + II IgG1
(clone E9; Dako Cytomation, USA; diluted 1:50 with 1%
BSA in PBS), rabbit polyclonal anti-megalin IgG (H-245,
Santa Cruz Biotechnology, USA; diluted 1:200 with 1%
BSA in PBS), rabbit polyclonal anti-GFAP IgG (Abcam,
UK; diluted 1:5000 with 1% BSA in PBS) or rabbit poly-
clonal anti-myelin PLP IgG antibodies (Abcam, UK,
diluted 1:1000 with 1% BSA in PBS) were added to tissue
samples and incubated overnight at 4 C in a humid envi-
ronment, followed by a 45-min incubation with peroxi-
dase-labeled polymer conjugated to goat anti-mouse or
anti-rabbit immunoglobulins containing carrier protein
linked to Fc fragments to prevent nonspeciﬁc binding.
The immunoreactions’ product was visualized by adding
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terstained with hematoxylin, dehydrated through graded
ethanol, and mounted using Entelan (Sigma–Aldrich,
Germany). The photomicrographs were taken and
examined under Olympus BX51 light microscope
(Olympus, Japan).Immunoﬂuorescence
Immunoﬂuorescent labeling was performed on paraﬃn
embedded brain tissue slides. Tissue sections were
submitted to heat-induced antigen retrieval and
nonspeciﬁc binding was blocked by a one-hour
incubation with 1% BSA in PBS containing 0.001%
NaN3 at room temperature. Diﬀerent combinations of
double immunoﬂuorescence labeling were then carried
out combining suitable primary and secondary
antibodies, to detect expressions of MTs and megalin
on astrocytes (GFAP+ cells), neural and glial
progenitors cells and neuroblasts (GFAP+, nestin+,
DCX+, NG2+, O4+ cells) and mature neuronal cells
(NeuN+ cells), as well as their co-expression in
diﬀerent regions of the brain. For that purpose the
following primary antibodies were used: mouse anti-MT
I + II IgG1 (clone E9; Dako Cytomation, USA; diluted
1:50), rabbit anti-megalin IgG (H-245, Santa Cruz
Biotechnology, USA; diluted 1:50), rabbit anti-GFAP IgG
(Abcam, UK; 1:5000), rabbit anti-myelin PLP IgG
(Abcam, UK, 1:1000), rabbit anti-nestin IgG (Sigma–
Aldrich, USA, 1:100), rabbit anti-NG2 IgG
(Merckmillipore, USA, 1:200), rabbit anti-NeuN IgG
(Abcam, UK, 1:100), rabbit anti-doublecortin IgG
(Abcam, UK, 1:500), mouse anti-O4 IgM (R&D
Systems, USA, 1:200), mouse anti-PCNA IgG2a
(Abcam, UK, 1:1000) and mouse anti-AKT1 (phospho
T308) IgG1 (Abcam, UK, 1:50).
Primary antibodies were diluted in blocking solution
and incubated with tissue sections overnight at 4 C in a
humid environment. To visualize immunocomplexes, the
following secondary antibodies were used: Alexa Fluor
goat anti-mouse IgG1 555 nm (Molecular probes, USA,
1:500), Alexa Fluor donkey anti-rabbit IgG 488 nm
(Molecular Probes, USA, 1:300), Alexa Fluor donkey
anti-rabbit IgG 594 nm (Molecular Probes, USA, 1:500),
Alexa Fluor goat anti-mouse IgG2 488 nm (Molecular
probes, USA, 1:300), Alexa Fluor goat anti-mouse IgM
488 nm (Molecular probes, USA, 1:300) and Alexa Fluor
goat anti-mouse IgG1 488 nm (Molecular probes, USA,
1:300).
Secondary antibodies were diluted in blocking solution
and incubated with tissue sections in dark for 1 h at room
temperature in a humid environment. Nuclei were
visualized with 40,6-diamidino-2-phenylindole,
dihydrochloride (DAPI, Molecular Probes, USA). Images
were captured on Olympus imaging system BX51
equipped with DP71CCD camera (Olympus, Tokyo,
Japan) and CellF imaging software was used.Proximity ligation assay
To determine metallothionein I + II and megalin
interaction, we performed proximity ligation assay (PLA)on paraﬃn embedded tissue sections using Duolink PLA
in Situ Fluorescence kit (Sigma–Aldrich, Germany)
according to the manufacturer’s protocol with custom
blocking and antibody diluent solution. Brieﬂy, after
dewaxing and washing with PBS, slides were incubated
for 1 h at room temperature with the same blocking
solution as used for immunoﬂuorescence studies (1%
BSA in PBS) but without NaN3. Subsequently, slides
were incubated overnight at 4 C in a humid
environment with mouse anti-MT I + II IgG1 (clone E9;
Dako Cytomation, USA) and rabbit anti-megalin IgG
(H-245, Santa Cruz Biotechnology, USA), both diluted
1:50 in blocking solution. After washing in PBS, anti-
rabbit MINUS and anti-mouse PLUS PLA probes diluted
1:5 with 1% BSA in PBS and sited at room temperature
for 20 min were added to tissue slides and incubated in
a pre-heated humidity chamber for 1 h at +37 C.
Afterward, slides were washed with 1 Wash Buﬀer A
(prepared according to enclosed instructions) and the
ligation process was performed by incubating slides with
Ligation-Ligase solution (Ligation stock diluted 1:5 in
nuclease-free water with immediately added ligase at a
1:40 dilution) in a pre-heated humidity chamber for 30
min at +37 C. After washing in 1 Wash Buﬀer A,
ampliﬁcation was done by incubating samples with
Ampliﬁcation-Polymerase solution (Ampliﬁcation stock
diluted 1:5 in nuclease free water with immediately
added Polymerase at a 1:80 dilution) in a pre-heated
humidity chamber for 100 min in the dark at +37 C.
Tissue slides were subsequently washed twice in
1 Wash Buﬀer B (prepared according to enclosed
instructions) for 10 min, and then twice in 0.01 Wash
Buﬀer B for 1 min, continuously protected from the light.
Nuclei were visualized by DAPI staining (1:1000 in PBS
for 5 min; Invitrogen, USA). Slides were afterward
washed in PBS and mounted with Mowiol (Sigma–
Aldrich, Germany). The microphotographs were
taken under ﬂuorescent microscope equipped with
DP71CCD camera (Olympus, Japan) and CellF imaging
software.
Immunohistochemical staining quantiﬁcation
Immunohistochemical staining quantiﬁcation of MT,
GFAP, PLP and megalin expression in diﬀerent regions
of the brain was performed using Image J software.
Captured images were converted to 16-bit images
based on gray-scale with diﬀerent gray intensity range,
depending on the strength of immunohistochemical
signals. Digital background subtraction was done and
intensities were inverted in order to achieve positive
correlation of staining intensity and brightness as a gray
intensity. Withal, threshold was manually set so that any
background brightness was considered as the value 0,
and background signals were completely excluded from
the calculation. Fifteen regions of interest (ROIs) were
arranged to cover the area being analyzed and mean
gray values were measured. ROI surface size always
was equal for each analyzed area. The measurements
were made on three separate slides per animal, in ﬁve
animals/group. The data were expressed as mean gray
value ± SE.
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The statistical analyses were performed using Statistica
software version 12 (StatSoft Inc., Tulsa, OK, USA).
The distribution of data was tested for normality using
the Kolmogorov–Smirnov test. Diﬀerences between
groups were assessed with a one-way analysis of
variance (ANOVA) followed by the post hoc Scheﬀe´
test. All data are given as arithmetic mean ± standard
error of the mean (SEM). The level of signiﬁcance was
set at p< 0.05.RESULTS
Expression of metallothionein-I + II and megalin in
the brain of mice subjected to diﬀerent cuprizone
feeding protocols
Expression proﬁling of metallothionein-I + II and megalin
was made in female C57BL/6 mice fed by 0.25% CPZ
(w/w) during 1, 3 and 5 weeks and in those fed by
CPZ during 5 weeks and sacriﬁced 2 weeks after CPZ
withdrawal. The results were compared with ﬁndings in
mice maintained on normal chow (Fig. 1).
MT-I/II immunoreactivity. In mice maintained on
normal diet the expression of MT-I/II proteins in the
brain was low and restricted mostly to ependymal cells
and subventricular zone (SVZ) (Fig. 2A a). CPZ-
supplemented diet induced, however, a high MTFig. 1. Study design. Female C57BL/6 mice were fed with a 0.25% cuprizon
sacriﬁced next day after the expiration of the dietary intoxication protocol or
weeks). Control mice received the same chow without CPZ. At the end of
combination of Ketamine and Xylasine, transcardially perfused with c
paraformaldehyde and sacriﬁced by exsanguinations. Tissue samples of th
ﬁxed in 4% paraformaldehyde solution during 24 h. Paraﬃn slices were prepa
metallothioneins and megalin expression and phenotypic analysis of aﬀected
mouse brain (Sidman et al., 2004) http://www.hms.harvard.edu/research/brai
cortex, deep white matter, corpus callous, hippocampus, lateral ventricle, cer
area of the coronal sectioning.overexpression. It was observed already one week after
feeding with CPZ (Fig. 2B a–f), but the greatest
upregulation of MT immunoreactivity was found in mice
fed with CPZ for ﬁve weeks and sacriﬁced immediately
after the treatment with CPZ (Fig. 2B m-s; p< 0.001 in
comparison with mice fed by standard food; Fig. 2C). In
all groups the expression of MTs arose in white matter
(corpus callosum and capsula interna (Fig. 2B a, g, m
and, b, h, n, respectively) and in hilus of cerebellum (s),
but also in the cortex (c, i, o) and in granular and
molecular layer of cerebellum (f, l, s, w). Besides, strong
MT immunostaining was found particularly in SVZ of
lateral ventricles and in SGZ and molecular layer of the
dentate gyrus (DG) (Fig. 2B d, j, p, z and k, l, e, y,
respectively), pointing to the involvement of MTs in the
processes of adult neurogenesis. Most of the MT-
positive cells in white matter and cortex had astrocyte-
like features and around many of them a strong
extracellular MT immunoreactivity was found,
suggesting that MT-I/II were secreted from these cells
(Fig. 2B n, o, y). The semi-quantitative analysis also
showed that MT-I/II immunostaining in the brain of CPZ-
fed mice was in all regions signiﬁcantly greater than that
found in mice maintained on normal chow (Fig. 2C).
Megalin immunoreactivity. Feeding with CPZ-
supplemented diet induced also the upregulation of the
megalin, a suggested receptor for MTs. As shown in
Fig. 3B (g–l) megalin immunoreactivity started to rise ine (CPZ) (w/w) supplemented diet during 1, 3 and 5 weeks. They were
2 weeks after the withdrawal of CPZ given for 5 weeks (group 5+2
the experiment six animals/group were deeply anaesthetised with a
old phosphate-buﬀered saline (PBS, 10 mM, pH 7.4) and 4%
e brain were rapidly removed, coronally or sagittally dissected and
red for immunohistochemical and immunoﬂuorescent determination of
cells. On representative coronal and sagittal microphotographs of the
n/atlas.html) the subﬁelds examined in this study are shown (cerebral
ebellar cortex and medulla). The line on the sagittal view denotes the
Fig. 2. Cuprizone-supplemented diet induces the upregulation of MT-I/II immunoreactivity in the brain. Representative immunohistochemical
pictures show staining with anti-MT-I/II antibody in paraﬃn-embedded sections of the brain tissue obtained from C57BL/6 mice fed: (A) by normal
chow and (B) by 0.25% CPZ (w/w) during the one, three and ﬁve weeks and sacriﬁced immediately after CPZ feeding or after 7 weeks (5 weeks of
CPZ feeding +2 weeks of normal diet). (C) MT-I/II immunoreactivity in diﬀerent brain regions. The measurements were made by ImageJ software
analysis on 15 regions of interest (3 ROI/mouse  5 animals/group). Values are expressed as mean gray value ± SE (N= 15). *p< 0.05.
**p< 0.01 and ***p< 0.001 in comparison with mice fed by normal diet.
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MTs, its expression was maximally upregulated in
tissues of mice treated with CPZ for 5 weeks (Fig. 3B
m–s). At that time a high number of megalin-positive
cells were found in corpus callosum (Fig. 2B m) and incapsula interna (Fig. 3B n), but particularly in frontal
cortex, where megalin immunoreactivity was found
mainly in the nuclei of these cells (Fig. 3B o). Besides,
high megalin immunoreactivity was found in choroid
plexus (Fig. 3B p), in SVZ and SGZ of DG (Fig. 3B r),
Fig. 3. Cuprizone-supplemented diet induces the upregulation of megalin/LRP-2 immunoreactivity in the brain. Representative immunohisto-
chemical pictures show staining with anti-megalin antibody in paraﬃn-embedded sections of the brain tissue obtained from C57BL/6 mice fed:
(A) by normal chow and (B) by 0.25% CPZ (w/w) during the one, three and ﬁve weeks and sacriﬁced immediately after CPZ feeding or after 7 weeks
(5 weeks of CPZ feeding +2 weeks of normal diet). (C) Megalin immunoreactivity in diﬀerent brain regions. The measurements were made
by ImageJ software analysis on 15 regions of interest (3 ROI/mouse  5 animals/group). Values are expressed as mean gray value ± SE (N= 15).
*p< 0.05. **p< 0.01 and ***p< 0.001 in comparison with mice fed by normal diet.
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layers) and cerebellar white matter (Fig. 3B s). The
quantitative analysis also showed that megalin
immunostaining in the brain of CPZ-fed mice wassigniﬁcantly greater than that in mice maintained on
normal chow (Fig. 3C).
The described data clearly showed that intoxication
with CPZ led to upregulation of both MT-I/II and their
H. Jakovac et al. / Neuroscience 388 (2018) 69–86 75receptor, as well as that the feeding with CPZ for 5 weeks
could be used as the most suitable protocol for the
characterization of phenotype of involved cells and
further analysis of relationship between the MTs and
megalin in diﬀerent brain areas.Relationship of MT-I/II to processes of demyelination
and astrogliosis induced by CPZ
The data obtained by immunohistochemical
determination of proteolipid protein (PLP) (Fig. 4A) and
GFAP (Fig. 4B) showed that CPZ-supplemented dietFig. 4. Cuprizone-supplemented diet induces acute demyelination and ma
brain. Representative immunohistochemical pictures show: (A) staining with
(B) staining with anti-GFAP antibodies in paraﬃn-embedded sections of the br
C57BL/6 mice fed by normal chow (a–d) and from mice fed by 0.25% CPZ (w/
and sacriﬁced immediately after CPZ feeding (e–l). (C) PLP and GFAP imm
callosum, hippocampus and cerebellum. The measurements were made by Im
on 15 regions of interest (3 ROI/mouse  5 animals/group). Values are ex
value ± SE (N= 15). **p< 0.01 and ***p< 0.001 in comparison with miceafter 5 weeks led to high demyelination and marked
astrogliosis in white matter of cerebrum and cerebellum.
PLP immunoreactivity was predominantly reduced in
corpus callosum (Fig. 4A a, b versus e, f) and cerebellar
medulla (d versus h), but also in hippocampus (Fig. 4A
c versus d). Staining with anti-GFAP antibodies also
showed that in these zones were present in numerous
hypertrophic astrocytes (Fig. 4B e–l). The semi-
quantitative analysis of PLP and GFAP expression in
these brain regions also showed that changes induced
by CPZ feeding were signiﬁcantly diﬀerent from those
found in untreated mice (Fig. 4C p< 0.01 andssive astrogliosis in the
anti-PLP antibodies and
ain tissue obtained from
w) during the ﬁve weeks
unoreactivity in corpus
ageJ software analysis
pressed as mean gray
fed by normal diet.p< 0.001), conﬁrming that chronic
CPZ intoxication led to high
demyelination in the brain and
subsequent massive astrogliosis
(Torkildsen et al., 2008; Kipp et al.,
2009; Zendedel et al., 2013).
Besides, the data obtained by dou-
ble immunoﬂuorescent labeling with
anti-PLP and anti-MT + I + II anti-
bodies clearly showed that in
demyelinating zones of corpus callo-
sum and capsula interna were pre-
sent numerous astrocyte-like cells
that expressed high cytoplasmic
MT immunoreactivity (Fig. 5a–d). In
addition, the granular expression of
MT on astrocytic or neuronal ﬁla-
ments in white matter was found
(Fig. 5 g, h, arrows).
MT/Megalin interactions in CPZ-
aﬀected brain regions
Owing to current postulation that
astrocyte-derived MTs may
modulate cell signaling and
neuronal growth and repair through
direct contact with megalin
(Ambjørn et al., 2008; Chung et al.,
2008a; West et al., 2011) we
attempted to visualize also the pos-
sible interaction between the cells
expressing MT and megalin in brain
regions that were highly aﬀected by
CPZ intoxication using double
immunoﬂuorescence and PLA.
Corpus callosum and capsula
interna. In this context double
staining with anti-GFAP and anti-
MT antibodies conﬁrmed that
feeding with CPZ for ﬁve weeks
induced a high astrogliosis in
corpus callosum and appearance of
numerous hypertrophic GFAP-
positive astrocytes that co-
expressed MT (Fig. 6A a–f).
Moreover, around many of them a
high extracellular MT
immunoreactivity was clearly seen
Fig. 5. In CPZ-fed mice the MT-I/II overexpression is induced on astrocyte-like cells in areas of demyelination. Representative immunoﬂuorescent
pictures show staining with anti-PLP and anti-MT-I/II antibodies in paraﬃn-embedded sections of the brain tissue obtained from C57BL/6 mice fed
by 0.25% CPZ (w/w) during the ﬁve weeks and sacriﬁced immediately after CPZ feeding (e–l).
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matter of CPZ-treated mice were present
oligodendrocyte progenitors, since numerous cells were
stained by monoclonal antibody against NG2 chondroitin
sulfate proteoglycan and O4 antigen (Fig. 6A g–i). Only
some of them co-expressed MT-I/II (Fig. 6A g–h,
arrows), but according to the staining with anti-PCNA
antibodies many of MT+ cells were surrounded by
mitotically active cells (Fig. 6D).
Double staining with anti-MT and anti-megalin
antibodies also showed that in corpus callosum and
white matter were present numerous small (Fig. 6B a–c)
and some large megalin+/MT- cells, located near the
cortical zone (Fig. 6B d). Staining with NeuN antibodies
visualized that beneath corpus callosum were present
some megalin-positive neurons (Fig. 6C, arrows).
Cortex. Cuprizone feeding during 5 weeks increased
also the number of GFAP+/MT+ astrocytes in cortical
gray matter and similarly as it was found in the white
matter, around many of them the extracellular MT
immunoreactivity was seen (Fig. 7A a–c, arrows).
Besides, implying that in this area the secreted MTs
were recognized by their receptors and internalized into
the cell, in the cortex were found numerous megalin-
positive cells, which showed MTs immunoreactivity in
their membranes or in cytoplasm (Fig. 7B a–c, inserts).
The neuronal phenotype of these cells was conﬁrmed
by co-staining with NeuN (Fig. 7C a–c). Moreover,
implying that MT was internalized also in some
oligodendrocyte progenitors the spots of MTs
immunoreactivity were found in NG2+ cells localized
near the white matter (Fig. 7A d, e) and on numerous
O4 cells (Fig. 7A f).
The described data, obtained by double
immunoﬂuorescence, clearly showed that MT-I/II and
megalin co-localize in the NeuN+ cortical neurons and
in some oligodendrocyte progenitors (Fig. 7), implying
that in CPZ-intoxicated mice extracellular MTs might via
the megalin/LRP2 modulate functional state of target
cells. To proof this possibility and to visualize theprotein–protein interactions we used the PLA, which
enables in situ recognition of two potentially interacting
proteins using a pair of speciﬁc antibodies conjugated to
a matched pair of short single-stranded oligonucleotides
(So¨derberg et al., 2008). Besides, since numerous stud-
ies have shown that ligation of megalin/LRP2 receptor
may activate AKT1/Protein kinase B (PKB, RAC-alpha
serine threonine-protein kinase), which through phospho-
rylation and inhibition of a range of downstream sub-
strates regulates multiple signaling pathways, including
neuronal survival (Noshita et al., 2001; Li et al., 2001a,;
Endo et al., 2006; May et al., 2007; Ambjørn et al.,
2008; Auderset et al., 2016), in megalin-positive and
NeuN-positive cells we estimated also the presence of
phospho-AKT1 (pAKT1) as a result of MT-I/II/megalin
interaction. The data obtained by PLA and with antibody
pair against MT-I/II and megalin clearly conﬁrmed the
MT-I/II not only co-localized with megalin (Figs. 7B a–c
and 8A a–c), but also interacted with its receptor in corti-
cal tissue of mice fed by CPZ-supplemented diet for 5
weeks (Fig. 8A c–d). Moreover, double immunoﬂuores-
cence analysis with antibodies against megalin and
pAKT1 (phospho threonine 308), and those against NeuN
and pAKT1 revealed that in numerous megalin-positive
cells was upregulated the expression of phospho-Akt
(Fig. 8B a–c), as well as that it was localized particularly
in nucleus of cortical NeuN-positive neurons (Fig. 8C a–
c). Since similar changes were not observed in untreated
mice (Fig. 8B d–f and C d–f), the data imply that in CPZ-
treated mice highly expressed megalin/LRP2 contributed
not only to the internalization of extracellular MT-I/II into
neurons, but also to triggering of signal transduction path-
ways that protect the cell against the toxic eﬀects of CPZ.
Cerebellum. The data obtained by double
immunoﬂuorescence conﬁrmed that intoxication with
CPZ induced a high MT-I/II upregulation in both
cerebellar hilus (Fig. 9A a) and cerebellar cortex
(Fig. 9A d), as well as that majority of these cells were
GFAP+ astrocytes (Fig. 9A b, c) and nestin+ Purkinje
cells (Fig. 9 e, f). Moreover, the data showed that in
Fig. 6. In cerebral white matter of mice feed by cuprizone-supplemented diet are present astrocytes
that abundantly express MT I + II and juxtapositioned cells that express NG2, megalin and PCNA
Representative immunoﬂuorescent pictures show: (A) relationship of MT+ cells to GFAP+
astrocytes (a–f) and NG2+ or O4+ cells (g–i), B) relationship of MT+ cells to megalin-positive
cells (a–d); C) NeuN+ cells co-expressing megalin and D) relationship of MT+ cells to PCNA+ cells.
Brain tissue was obtained from C57BL/6 mice fed by 0.25% CPZ (w/w) during the ﬁve weeks and
sacriﬁced immediately after CPZ feeding.
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Fig. 9B a–f), that were in direct contact with MT+ cells
in molecular layer (Fig. 9B b, c), as well as that several
megalin+ cells were NeuN+ neurons (Fig. 9B d–f).
Hippocampus. Double immunoﬂuorescence with anti-
MT-I/II antibodies and antibodies against stage-speciﬁc
markers typical for neurogenic and gliogenic stem/
progenitor cells (Fig. 10A) clearly demonstrated that
MTs might have a high inﬂuence on processes of self-
renewal in neurogenic niches located in SGZ of
hippocampus and in SVZ of the lateral ventricle.
In the SGZ of DG of mice fed by CPZ for 5 weeks we,
thus, found MT immunoreactivity in numerous radial glia-
like cells expressing GFAP and on their protrusions
extending into the granular cell layer (GCL) (Fig. 10B a–c),on some cells expressing nestin
(Fig. 10B g–i), as well as in several
DCX+ cells (Fig. 10B, j–l),
implying that MT had aﬀected type
I cells, non-radial precursors (type
II cells) and intermediate progenitor
cells or neuroblasts (type 2b or
type 3 cells) (Kempermann et al.,
2004; Ming and Song, 2011). More-
over, MT-immunoreactivity was
found in several NG2+ oligodendro-
cyte progenitors in molecular layer
of DG (Fig. 10B m–o), pointing to
the potential inﬂuence of MTs on
cells destined to oligodendroglial lin-
eage. In addition, we found MTs
expression in vascular and GFAP+
cells in the hippocampal hilus
(Fig. 10B f), in some large GFAP+
cells in CA1 region of hippocampus
(Fig. 10B, insert on f), as well as in
some mature NeuN+ neurons in
GCL (Fig. 10B p–s).
The data also showed that in
SGZ numerous cells co-expressed
MT-I + II and megalin
immunoreactivities (Fig. 10C a–c).
According to the phenotypic
markers some of them were nestin
+ cells, located in GCL and in the
hilus (Fig. 10C d–f) and DCX+
neuroblasts migrating into GCL
(Fig. 10C g–i). Megalin
immunoreactivity was, however,
also found in some NeuN+
interneurons in the hilus and in all
mature NeuN+ neurons in GCL of
hippocampus (Fig. 10C j–l). The
data obtained with PLA, also
clearly showed that MT interacted
with megalin in several cells
located in subgranular, granular
and molecular layer, as well as in
CA1 region of hippocampus
(Fig. 10D).Subventricular zone. Similar analysis made in SVZ in
anterior horn of lateral ventricle clearly showed that MT-
I/II were also extensively expressed in this neurogenic
niche, which generate new neurons that migrate through
the rostral migratory stream (RMS) to the olfactory bulb
to become diﬀerent subtypes of interneurons (reviewed
by (Zhao et al., 2008; Ming and Song, 2011; Gonzalez-
Perez, 2012) (Fig. 11A). As shown on Fig. 11 high MT
immunoreactivity was found in GFAP+ cells (Fig. 11B
(a–c) and in ependymal cells lining the lateral ventricle,
which surrounded the neurogenic niche containing
numerous PCNA+ (Fig. 11B g–i) and DCX+ cells
(Fig. 11B j–l), implying that in SVZ MT-I/II aﬀected the
radial-glia like cells (B cells) and contributed to the sur-
vival of transient amplifying cells (C cells) and neuroblasts
Fig. 7. In cerebral cortex of mice feed by cuprizone-supplemented diet are present astrocytes that
abundantly express MT-I/II, NG2+ and O4+ oligodendrocyte progenitors that express MTs and
NeuN+ neurons that express megalin and MTs A Representative immunoﬂuorescent pictures show:
(A) GFAP+ astrocytes (A a–c) and NG2+ or O4+ oligodendrocyte progenitors (A d–f) co-
expressing MTs; (B) megalin+ cells co-expressing MTs (B, a–c); C) NeuN+ neurons co-expressing
megalin (a–c). Brain tissue was obtained from C57BL/6 mice fed by 0.25% CPZ (w/w) during the ﬁve
weeks and sacriﬁced immediately after CPZ feeding (e–l).
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similarly to mature NeuN+ cells located around the lat-
eral ventricle (Fig. 11A p–s). In contrast, an extensive
MT immunoreactivity was found in small and large nes-
tin+ cells in layers adjacent to the lateral ventricle
(Fig. 11B d–f), as well as in numerous NG2+ oligoden-
drocyte progenitors (Fig. 11B m–o), suggesting that MT
might contribute to oligodendrocyte regeneration. The
data also showed that several MT+ cells co-expressed
the megalin (Fig. 11C a–c), as well as that this receptor
was present on numerous nestin+ cells (Fig. 11B d–e)
and on some DCX+ neuroblasts that formed a chain of
migrating cells (Fig. 11C g–i). Importantly, the data
obtained by PLA conﬁrmed that in SVZ MT interacted with
megalin in numerous cells (Fig. 11D).
DISCUSSION
In agreement with a number of previous reports in the
current study we conﬁrm that feeding of mice with CPZ
leads to a robust demyelination and profoundastrogliosis in diﬀerent white and
gray matter regions of the brain
(Matsushima and Morell, 2001;
Kipp et al., 2009; Skripuletz et al.,
2011; Zendedel et al., 2013; Gudi
et al., 2014; Praet et al., 2014), as
well as to a high upregulation of
MTs (Zatta et al., 2005; Biancotti
et al., 2008). However, as a novelty
we describe here the relationship of
MT + I/II to their receptor megalin/
LRP-2 and temporal and spatial dis-
tribution of these molecules during
the CPZ-intoxication lasting 1, 3 or
5 weeks, as well as during repara-
tory, cuprizone-free period.
In this context our data show that
MT expression in the brain
correlated with the duration of CPZ
intoxication (Fig. 2), as well as
that in mice fed by CPZ for
5 weeks the intracellular MT
immunoreactivity might be found
particularly on hypertrophic and
hyperplastic astrocytes in the
demyelinating areas of white matter
and in the cortex (Figs. 6 and 7)
and in ependymal and epithelial
cells surrounding the stem cells
niche in SGZ and SVZ (Figs. 10
and 11). Moreover, supporting the
hypothesis that some eﬀects of
MTs might be mediated by direct
interaction of secreted MTs with
their receptors (Aschner and West,
2005; Ambjørn et al., 2008; West
et al., 2008; Chung et al., 2008b),
we show herein that in several
megalin-positive cortical neurons
(Figs. 7 and 8) and in glial and neu-ral stem/progenitors cells (Figs. 10 and 11) the membra-
nous or cytosolic ﬂuorescent immunostaining of MT-I/II
might be found. Importantly, in these areas the direct
MT-I/II/megalin interaction was also conﬁrmed by PLA
(Figs. 8A d–f, 10D and 11D). Moreover, in megalin-posi-
tive cortical neurons an increased phospho-Akt1
(Thr308) expression was shown (Fig. 8B, C a–c), indicat-
ing that in CPZ-fed mice the accelerated phosphorylation
of Akt1/PKB might be associated with activation of cellular
survival pathways.
The results are in high agreement with current
knowledge showing that neuroprotective eﬀects of MTs
might be attributed to both intracellular and extracellular
forms of MTs (Hidalgo et al., 1991; Aschner and West,
2005; Penkowa, 2006; Nielsen et al., 2007; West et al.,
2008; Chung et al., 2008a; Pedersen et al., 2009), as well
as with the postulation that binding of MTs to surface
receptors of the LRP family might regulate the processes
of MT endocytosis and activate signal transduction path-
ways that promote neurite outgrowth and survival
(Ambjørn et al., 2008; Chung et al., 2008b; West et al.,
Fig. 8. In mice fed by cuprizone MT-I/II interacts with megalin in cortical neurons and enhances
the phosphorylation of AKT1/Protein kinase B (RAC-alpha serine threonine-protein kinase).
Representative images show: (A) Co-localization (orange) of MT-I/II (red) and megalin (green) in
cortical neurons detected by double-immunoﬂuorescent staining (a–c) and interaction between the
MT-I/II and megalin (red ﬂuorescence) detected by proximity ligation assay (c, d). Blue
ﬂuorescence (DAPI) is used as counterstain. (B) Upregulation of phospho-AKT1/Protein kinase
B (phospho Thr308) (green) in megalin-positive cortical cells (red) detected by double
immunoﬂuorescence in the brain tissue of mice fed by CPZ during the ﬁve weeks (a–c) and in
those maintained on normal chow (d–f). (C) Upregulation of phospho-AKT1/Protein kinase B
(phospho Thr308) (green) in NeuN-positive cortical neurons (red) detected by double immunoﬂu-
orescence in mice fed by CPZ (a–c) and in those maintained on normal chow (d–f). (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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processes (Li et al., 2001a; May et al.,
2007; Spuch et al., 2012; Auderset
et al., 2016).
The mechanisms leading to MT
upregulation during CPZ intoxication is
still unclear, but it is well known that
the transcription of this family of
evolutionarily highly conserved small
(6–7 kDa), metal-binding proteins is
regulated by factors that aﬀect the
promoter region of the multigene
complex containing metal-responsive
regulatory elements (MREs),
controlled by the metal regulatory
transcription factor (MTF)-1, as well
as antioxidant (or electrophile)
response elements (AREs), signal
transducer and activator of
transcription 3 (STAT-3) and
glucocorticoid response elements
(GREs) that respond to redox status,
cytokine signaling and stressful
conditions, respectively. This leads to
the protection of cells against the
toxicity of divalent heavy metal cations
and oxidative stressors, such as nitric
oxide, peroxynitrite, hydrogen
peroxide and superoxide providing
thus resistance against apoptosis/
necrosis induced by cytokines and
other noxious insults (Andrews, 2000;
Miles et al., 2000; Hidalgo et al.,
2001; Coyle et al., 2002; Sato and
Kondoh, 2002; Inoue et al., 2009;
Maret, 2011).
Based on this knowledge we may
assume that during CPZ intoxication
the transcription of MT genes and
synthesis of MT-I/II proteins were
induced by combination of various
triggers. One of the initial might be the
induction of oxidative stress and
mitochondrial damage since CPZ, as
bidentate ligand with two hydrazides,
selectively binds cupric (Cu2+) ions
or stabilizes Cu3+ oxidation state in
the cells (Faizi et al., 2016). This leads
to in situ Cu chelation and alterations in
proper functioning of metalloenzymes,
such as Cu/Zn-superoxide dismutase,
cytochrome c oxidase, ceruloplasmin,
or dopamine beta-monooxygenase
and to the dysfunction of oxidative
phosphorylation and energy metabo-
lism (Matsushima and Morell, 2001;
Zatta et al., 2005; Gudi et al., 2014;
Praet et al., 2014). Consequently,
Fig. 9. Eﬀect of cuprizone-supplemented diet on cerebellum. Representative immunoﬂuorescent
pictures show: (A) MT-I/II expression on GFAP+ astrocytes (a–c) and nestin+ cells (d–f). (B)
Relationship of megalin+ cells to MT+ cells (a–c) and to NeuN+ neurons (d–e). Brain tissue was
obtained from C57BL/6 mice fed by 0.25% CPZ (w/w) during the ﬁve weeks and sacriﬁced
immediately after CPZ feeding (e–l).
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require high energy for myelin production, while other glial
cells, such as microglia, astrocytes and OPC, as well as
neuronal cells are less vulnerable to oxidative stress
(Be´nardais et al., 2013). Our ﬁndings imply that MTs con-
tributed to this protection, similarly as the reports showing
that following CPZ treatment OLGs express only low
amounts of MTs, in contrast to astrocytes (Biancotti
et al., 2008).
Neuroprotection may be based on antioxidant activity
of MTs and scavenging of reactive oxygen species
(ROS), but since antioxidant eﬀect of MTs is coupled
also with release of zinc ions there is a possibility that
the activation of multiple Zn-dependent transcription
factors and proteins contributed to MT-triggered
neuroprotective processes (Mocchegiani et al., 2007;
Levenson and Morris, 2011; Maret, 2011; Ruttkay-
Nedecky et al., 2013). In addition, it should be taken into
account that during CPZ intoxication the redox properties
of MTs control also the release of Fe from ferritin and con-
tribute to elimination of Fenton-mediated radical damage
(Praet et al., 2014), as well as that MTs may preserve
the mitochondrial structural and functional integrity by
augmentation of coenzyme Q10, glutathione, ferritin,melatonin, and neuromelanin syn-
thesis in neurons (Sharma et al.,
2013). Furthermore, it was found
that the autophagocytozed or up-
regulated cytosolic MTs might
reduce intralysosomal oxidation
and lysosomal membrane destabi-
lization induced by oxidative stress
(Baird and Kurz, 2006).
Besides, we cannot exclude
either the possibility that during
CPZ intoxication the synthesis of
MTs was stimulated by activation of
MRE and STAT-3, since it was
found that administration of CPZ in
drinking water might increase the
concentration of Cu and Zn in the
brain and in the peripheral organs
(Zatta et al., 2005), as well as that
factors released from dying oligo-
dendrocytes led to activation of
macrophages and microglia and
subsequent secretion of various
chemokines, cytokines, and growth
factors, which might promote the
local inﬂammation and induce the
attraction of astrocytes and OPC in
demyelinating area (Pasquini et al.,
2007; Scheld et al., 2016). Impor-
tantly, in this context it was shown
that activation of an inﬂammatory
response by a combination of
growth factors led to myelin repair
in cuprizone-induced demyelinated
brain (Biancotti et al., 2008), as well
as that CPZ demyelination might
induce a unique inﬂammatoryresponse particularly in SVZ neurogenic niche, which
contributes to remyelination (Hillis et al., 2016).
Taken together these evidences show that during
CPZ intoxication the synthesis of MTs might be induced
by diﬀerent triggers and that their cytoprotective and
pro-regenerative actions might be related with
intracellularly synthesized or receptor-internalized MTs,
and with the activities of LRP-induced transduction
pathways activated after binding of MTs to their
receptors. The later proposal is in high agreement with
current knowledge showing that extracellular MTs play
an important role in the astrocyte–neuron response to
injury (Aschner and West, 2005; West et al., 2008;
Chung et al., 2008b) and with the ﬁndings that their neu-
ronal eﬀects might be mediated through direct binding to
surface receptors belonging to the LDL-R family, such
as megalin/LRP2 and LRP1 (Fitzgerald et al., 2007;
May et al., 2007; Ambjørn et al., 2008; West et al.,
2011; Leung et al., 2012; Auderset et al., 2016;
Landowski et al., 2016). These interactions enable the
cleavage of a C-terminal intracellular component of mega-
lin after endocytosis of MTs and lead to subsequent acti-
vation of signal transduction pathways that promote
regeneration, such as extracellular signal-regulated
Fig. 10. Eﬀect of cuprizone-supplemented diet on hippocampus. (A) A schematic illustration shows the neural stem cell niche in the subgranular
zone (SGZ) of the adult dentate gyrus (based on (Ming and Song, 2011) and cells types that might be detected by monoclonal antibodies used in
this study. Representative immunoﬂuorescent pictures show: (B) MT-I/II expression in GFAP+ cells (a–f), in nestin+ stem cells (g–f), in
doublecortin (DCX)+ neuroblasts/immature neurons (j–l), in NG2+ oligodendrocyte progenitors (m–o) and in mature NeuN+ neurons (p–s). (C)
Expression of megalin in MT+ cells (a–c), in nestin+ cells (d–f), in DCX+ cells (g–i) and in NeuN+ neurons (j–l). (D) Interaction of MT-I/II and
megalin in cells of SGZ, granular cell layer (GCL) and CA1, detected by proximity ligation assay. Brain tissue was obtained from C57BL/6 mice fed
by 0.25% CPZ (w/w) during the ﬁve weeks and sacriﬁced immediately after CPZ feeding (e–l).
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ment-binding (CREB) protein (Ambjørn et al., 2008) and
mitogen-activated protein kinase (Leung et al., 2012).
Furthermore, this may stimulate co-receptors, such as
the transthyretin (Fleming et al., 2009) or induce the acti-
vation of tropomyosin receptor kinase A and calcium sig-
naling (Landowski et al., 2016).
Our data seem to be in line with the reported
evidence, since in the late phase of CPZ intoxication we
found the increased MT immunoreactivity inside and
around the reactive astrocytes (Fig. 7A a–c), as well as
inside numerous megalin-positive cortical neurons
(Fig. 7B a–c) and OPCs at the cortico-medullary border
(Fig. 7A d, e, f). In addition, we emphasize thatMT/megalin interactions contribute also to the complex
biochemical signaling in germinal niches, where diﬀerent
intrinsic and extrinsic mechanisms regulate distinct
stages of adult neurogenesis (reviewed by
(Kempermann et al., 2004; Morrison and Spradling,
2008; Zhao et al., 2008; Kriegstein and Alvarez-Buylla,
2009; Ming and Song, 2011; Zhang and Jin, 2012). Within
this context, we show that in mice fed by CPZ for 5 weeks
MT-I/II and megalin expressions were upregulated in sev-
eral stem/progenitor cells (GFAP+, nestin+ cells, DCX
+ neuroblasts and NG2+ oligodendrocyte progenitors)
and in other cellular components that might play a promi-
nent role in regulating cell proliferation in the niches, such
as astrocytes, ependymal, perivascular and stromal cells
Fig. 11. Eﬀect of cuprizone-supplemented diet on subventricular zone of lateral ventricle. (A) A schematic illustration shows the neural stem cell
niche in the adult SVZ (based on (Ming and Song, 2011) and the cells types that might be detected by monoclonal antibodies used in this study.
Representative immunoﬂuorescent pictures show: (B) MT-I/II expression in GFAP+ cells (a–c), in nestin+ stem cells (d–f), in PCNA+ cells (g–i),
in doublecortin (DCX)+ neuroblasts/immature neurons (j–l), in NG2+ oligodendrocyte progenitors (m–o) and in mature NeuN+ neurons (p–s). (C)
Expression of megalin in MT+ cells (a–c), in nestin+ cells (d–f), and in DCX+ cells (g–i). (D) Interaction of MT-I/II and megalin on cells in SVZ,
detected by proximity ligation assay. Brain tissue was obtained from C57BL/6 mice fed by 0.25% CPZ (w/w) during the ﬁve weeks and sacriﬁced
immediately after CPZ feeding (e–l).
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intoxication the MT/megalin network contributed particu-
larly to the appearance or to the survival of new OPC,
since MT-I/II immunoreactivity was noticed in NG2-posi-
tive cells located both in SGZ and SVZ (Figs. 10 and
11). We may assume that they belong to proliferating
NG2+ OPC, since it was reported that during CPZ treat-
ment these cells might migrate from the SVZ and fornix to
the demyelinating corpus callosum and give rise to new
OLGs for remyelination (Mason et al., 2000;
Matsushima and Morell, 2001; Skripuletz et al., 2011).
However, their additional origin from parenchymal pro-
genitor pools and endogenous progenitors within demyeli-
nated lesions in white matter (Franklin and Gallo, 2014)
cannot be excluded.
Taken together, the ﬁndings imply that in target cells
MTs and megalin participated in signaling pathways
relevant for self-renewal and multipotential diﬀerentiation
of stem/progenitors and in processes that provide
protection against CPZ-induced oxidative stress.
Underlying mechanisms remain to be elucidated, but theﬁndings are in high agreement with hypothesis of
Chung, Hidalgo, West and collaborators, who clearly
showed that neuroregenerative eﬀects of MT-I/II might
be attributed not only to intracellular roles of MT-I/-II,
such as metal ions regulation and free radical
scavenging, but also to megalin mediated transport of
extracellular MTs into neurons (Hidalgo et al., 2001;
Chung et al., 2008a,b; West et al., 2011). Besides, the
data are in line with a growing number of studies, which
emphasize the signaling capacities of the LDL-receptor
family (Li et al., 2001b; May et al., 2005; Qiu et al.,
2006; Auderset et al., 2016). Regarding the later, we
show that binding of MT-I/II to megalin leads to activation
of the Akt1/PKB signaling, which as a major eﬀector of the
phosphoinositide 3-kinase (PI3-K) pathway may promote
the cell survival processes through regulation of genes
transcription, protein synthesis and metabolism (Franke
et al., 1997; Manning and Cantley, 2007; Hers et al.,
2011). It is also of particular interest that in CPZ-fed mice
we found that both megalin and pAkt1 (Thr308) were pre-
sent in the nucleus of cortical neurons (Fig. 8B and C a-c),
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cytosolic C-terminal domain of megalin, which had been
released from the plasma membrane by regulated
intramembrane proteolysis. Namely, these cytosolic frag-
ments contain critical signaling motifs for interaction with
a set of cytoplasmic adaptor and scaﬀold proteins and
in some instances enter the nucleus to regulate transcrip-
tion of target genes (Brown et al., 2000; Li et al., 2001b;
May et al., 2002). In our model, however, the underlying
signal transduction mechanisms remain to be clariﬁed,
since during CPZ intoxication the Akt signaling cascade
might be activated by diﬀerent mechanisms and pAkt
might aﬀect diverse cellular functions through phosphory-
lation and inhibition of a large number of downstream sub-
strates that regulate transcriptions of genes, protein and
fatty acid synthesis, glucose metabolism, cell proliferation
and survival, cell migration, and several aspects neural
functions (Manning and Cantley, 2007; Hers et al.,
2011). Besides, since LRP through its extracellular
domain may bind and internalize not only MTs, but at
least 40 diﬀerent ligands ranging from lipoprotein and pro-
tease inhibitor complex to growth factors and extracellular
matrix proteins, it should be taken into account that this
pleiotropism may increase the number of intracellular
pathways by which distinct LRP ligands may elicit their
eﬀects (Li, 2001; Li et al., 2001a; Kozyraki and Goﬄot,
2007; May et al., 2007; Spuch et al., 2012; Wagner and
Pietrzik, 2012). As the outcome, structurally and function-
ally distinct ligands of the LDLR family may be subjected
to controlled endocytosis and degradation and involved in
signaling mechanisms that control many crucial cell
functions.
Importantly, in this context it has been emphasized
that LRP1 and LRP2 also highly inﬂuence neural stem
cells proliferation and diﬀerentiation in neurogenic niches
and OPC proliferation and migration during development
and adulthood (reviewed by (Auderset et al., 2016). Rele-
vant to our data, it was found that megalin expression by
ependymal cells of lateral ventricle might regulate neu-
ronal stem cell proliferation in adult neurogenic niche, as
well as that megalin-activated pathways in oligodendro-
cytes might contribute to the maintenance of myelin in
embryonic mouse spinal cord and participate in the
translocation of signals from the cell membrane to the
nucleus (Wicher et al., 2005, 2006). Besides, pointing to
importance of MT-I/II/megalin interactions, Leung and
colleagues (2012) showed that MT-I/II might aﬀect regen-
erative axonal sprouting of dorsal root ganglion neurons
after physical axotomy and alter neurite outgrowth by acti-
vation of ERB and Akt signaling pathways (Leung et al.,
2012). They also clearly showed that the eﬀects of exoge-
nous MT-II on neuronal regeneration might be related with
its ability to reduce the inﬂammatory response of microglia
following TNFa stimulation and establish via LRP1-
receptor a supportive environment for axon growth
(Leung et al., 2018). Similarly, Landowski and co-authors
(2016) reported that MT-II might promote the regeneration
of nerve ﬁbers following capsaicin induced denervation in
rat skin and found that LRP-1 and LRP-2 receptors might
be actively recruited or up-regulated at the membrane
toward the MT-II gradient (Landowski et al., 2016).There is also a high possibility that during CPZ
intoxication MTs interacted with multiple other
extracellular and intracellular molecular cues that have
been implicated in the oligodendrocyte diﬀerentiation
and (re)myelination and exert permissive/promotional
and/or inhibitory eﬀects at the diﬀerent stages along the
OLG lineage (Fuller et al., 2007; Zhao et al., 2008; Ming
and Song, 2011; Franklin and Gallo, 2014; Praet et al.,
2014; Daynac et al., 2016; Gaesser and Fyﬀe-Maricich,
2016). However, although it is known that megalin and
LRP1 can inﬂuence the balance of growth factors and
morphogen signaling during neural development (Balordi
and Fishell, 2007; Gajera et al., 2010; Daynac et al.,
2016), the evidence about the MTs/megalin interactions
in these processes are still lacking.
Summarizing, we would like to emphasize that in this
study we also found that CPZ intoxication after 3 and 5
weeks induced a signiﬁcant upregulation of megalin
immunoreactivity in choroid plexus (Fig. 3C and B j, p,
v). Namely, this points to the possibility that in the later
phase of CPZ intoxication the receptor-mediated
endocytosis contributed to the uptake of MT-I/II and
other neuroprotective ligands, such as apolipoprotein E,
cholesterol, vitamin-binding proteins, hormones and
immunorelated proteins that were synthesized
elsewhere in the body (Gliemann, 1998; Li et al., 2001a;
Nuutinen et al., 2009). This would be also a plausible
explanation for the selective transport of some substrates
across the BBB and blood–cerebrospinal ﬂuid barrier in
cuprizone intoxication, since generally it does not induce
the breakdown of the blood–brain barrier (BBB)
(Hiremath et al., 2008; Skripuletz et al., 2011; Praet
et al., 2014). The ﬁnding might be of particular interest,
because the endogenous processes and therapies that
increase megalin expression at the choroid plexus may
control also the accumulation of brain Ab and enhance
the repair in the damaged brain, since LDL-R family are
involved in traﬃcking and processing of the amyloid
precursor protein (APP) and the uptake of apolipoprotein
J/clusterin, a binding protein for the Ab peptide (Zlokovic
et al., 1996; Alvira-Botero and Carro, 2010; Alvira-
Botero et al., 2010). In this context our data support the
current knowledge pointing to the therapeutic potential
of MT-I/II and peptides modeled from MT in AD and
MS, as well as in copper and zinc-dyshomeostasis, mito-
chondrial dysfunctions, aging and other neurodegenera-
tive disorders (Coyle et al., 2002; Mocchegiani et al.,
2007; Malavolta et al., 2008; Chung et al., 2008a, 2010;
Pedersen et al., 2009; Manso et al., 2011; West et al.,
2011; Sharma and Ebadi, 2013; Szewczyk, 2013).
In conclusion the data presented in this study show
that CPZ-induced demyelination is followed by high
upregulation of MT-I/II and megalin immunoreactivity in
astrocytes and epithelial and endothelial cells located in
cerebral and cerebellar white and gray matter, as well
as in choroid plexus and in numerous constituents of
the neurogenic niches (ependymal cells, GFAP+,
nestin+, doublecortin (DCX)+ and NG2+ cells) in
subgranular zone (SGZ) of DG and in SVZ of lateral
ventricles. Moreover, the data point to intercellular
transfer of MTs secreted from astrocytes, to direct
84 H. Jakovac et al. / Neuroscience 388 (2018) 69–86binding of MT-I/II to its receptor-megalin in target cells, as
well as to the activation of Akt1 phosphorylation cascade
in cerebral megalin-positive cortical neurons.
The data imply that MT I/II perform important
cytoprotective and growth regulating functions in
reparatory/remyelinating processes activated in the
brain after toxic demyelinating insults
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